Cargando…

Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme

BACKGROUND: Compensation and adaptation therapies have been developed to improve community functioning via improving neurocognitive abilities in people with schizophrenia. Various modes of delivering compensation and adaptation therapies have been found to be effective. The aim of this trial is to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dark, Frances, Newman, Ellie, Gore-Jones, Victoria, De Monte, Veronica, Garrido, Marta I., Dzafic, Ilvana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526389/
https://www.ncbi.nlm.nih.gov/pubmed/32993754
http://dx.doi.org/10.1186/s13063-020-04743-y
_version_ 1783588864572522496
author Dark, Frances
Newman, Ellie
Gore-Jones, Victoria
De Monte, Veronica
Garrido, Marta I.
Dzafic, Ilvana
author_facet Dark, Frances
Newman, Ellie
Gore-Jones, Victoria
De Monte, Veronica
Garrido, Marta I.
Dzafic, Ilvana
author_sort Dark, Frances
collection PubMed
description BACKGROUND: Compensation and adaptation therapies have been developed to improve community functioning via improving neurocognitive abilities in people with schizophrenia. Various modes of delivering compensation and adaptation therapies have been found to be effective. The aim of this trial is to compare two different cognitive interventions, Compensatory Cognitive Training (CCT) and Computerised Interactive Remediation of Cognition–Training for Schizophrenia (CIRCuiTS). The trial also aims to identify if mismatch negativity (MMN) can predict an individual’s response to the compensation and adaptation programmes. METHODS: This study will use a randomised, controlled trial of two cognitive interventions to compare the impact of these programmes on measures of neurocognition and function. One hundred clinically stable patients aged between 18 and 65 years with a diagnosis of a schizophrenia spectrum disorder will be recruited. Participants will be randomised to either the CCT or the CIRCuiTS therapy groups. The outcome measures are neurocognition (BACS), subjective sense of cognitive impairment (SSTICS), social functioning (SFS), and MMN (measured by EEG) in people with schizophrenia spectrum disorders. DISCUSSION: This trial will determine whether different approaches to addressing the cognitive deficits found in schizophrenia spectrum disorders are of comparable benefit using the outcome measures chosen. This has implications for services where cost and lack of computer technology limit the implementation and dissemination of interventions to address cognitive impairment in routine practice. The trial will contribute to the emerging evidence of MMN as a predictor of response to cognitive interventions. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12618000161224. Registered on 2 February 2018. Protocol version: 4.0, 18 June 2018.
format Online
Article
Text
id pubmed-7526389
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75263892020-10-01 Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme Dark, Frances Newman, Ellie Gore-Jones, Victoria De Monte, Veronica Garrido, Marta I. Dzafic, Ilvana Trials Study Protocol BACKGROUND: Compensation and adaptation therapies have been developed to improve community functioning via improving neurocognitive abilities in people with schizophrenia. Various modes of delivering compensation and adaptation therapies have been found to be effective. The aim of this trial is to compare two different cognitive interventions, Compensatory Cognitive Training (CCT) and Computerised Interactive Remediation of Cognition–Training for Schizophrenia (CIRCuiTS). The trial also aims to identify if mismatch negativity (MMN) can predict an individual’s response to the compensation and adaptation programmes. METHODS: This study will use a randomised, controlled trial of two cognitive interventions to compare the impact of these programmes on measures of neurocognition and function. One hundred clinically stable patients aged between 18 and 65 years with a diagnosis of a schizophrenia spectrum disorder will be recruited. Participants will be randomised to either the CCT or the CIRCuiTS therapy groups. The outcome measures are neurocognition (BACS), subjective sense of cognitive impairment (SSTICS), social functioning (SFS), and MMN (measured by EEG) in people with schizophrenia spectrum disorders. DISCUSSION: This trial will determine whether different approaches to addressing the cognitive deficits found in schizophrenia spectrum disorders are of comparable benefit using the outcome measures chosen. This has implications for services where cost and lack of computer technology limit the implementation and dissemination of interventions to address cognitive impairment in routine practice. The trial will contribute to the emerging evidence of MMN as a predictor of response to cognitive interventions. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12618000161224. Registered on 2 February 2018. Protocol version: 4.0, 18 June 2018. BioMed Central 2020-09-29 /pmc/articles/PMC7526389/ /pubmed/32993754 http://dx.doi.org/10.1186/s13063-020-04743-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Dark, Frances
Newman, Ellie
Gore-Jones, Victoria
De Monte, Veronica
Garrido, Marta I.
Dzafic, Ilvana
Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme
title Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme
title_full Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme
title_fullStr Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme
title_full_unstemmed Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme
title_short Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme
title_sort randomised controlled trial of compensatory cognitive training and a computerised cognitive remediation programme
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526389/
https://www.ncbi.nlm.nih.gov/pubmed/32993754
http://dx.doi.org/10.1186/s13063-020-04743-y
work_keys_str_mv AT darkfrances randomisedcontrolledtrialofcompensatorycognitivetrainingandacomputerisedcognitiveremediationprogramme
AT newmanellie randomisedcontrolledtrialofcompensatorycognitivetrainingandacomputerisedcognitiveremediationprogramme
AT gorejonesvictoria randomisedcontrolledtrialofcompensatorycognitivetrainingandacomputerisedcognitiveremediationprogramme
AT demonteveronica randomisedcontrolledtrialofcompensatorycognitivetrainingandacomputerisedcognitiveremediationprogramme
AT garridomartai randomisedcontrolledtrialofcompensatorycognitivetrainingandacomputerisedcognitiveremediationprogramme
AT dzaficilvana randomisedcontrolledtrialofcompensatorycognitivetrainingandacomputerisedcognitiveremediationprogramme